CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS

Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS explained in plain language.

Never miss a new study

Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS trials appear

Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new biologic drug prevent COPD Flare-Ups?

Disease control Not yet recruiting

This phase 2 trial tests whether galvokimig, an experimental biologic drug, can reduce the number of moderate-to-severe COPD flare-ups in people with chronic bronchitis. About 400 adults aged 40 to 80 with moderate-to-severe COPD will receive either galvokimig or a placebo as an …

Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS

Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS

Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CHRONIC BRONCHITIS trials appear

Can a new biologic drug prevent COPD Flare-Ups?